This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Be a Mom: Effectiveness of an eHealth Intervention for Promoting Maternal Mental Health (BeAMom)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04055974
Recruitment Status : Unknown
Verified March 2021 by Ana Fonseca, University of Coimbra.
Recruitment status was:  Recruiting
First Posted : August 14, 2019
Last Update Posted : March 18, 2021
Sponsor:
Collaborator:
Fundação para a Ciência e a Tecnologia
Information provided by (Responsible Party):
Ana Fonseca, University of Coimbra

Brief Summary:

Be a mom (a web-based cognitive-behavioral intervention) is being tested in another trial as a preventive intervention in the postpartum period (NCT03024645). However, given its content and the focus on developing and strengthening psychological resources, it is important to understand if Be a Mom is also effective in promoting maternal mental health of postpartum women who are not at risk of developing postpartum depression. Thus, the main goal of this research is to apply and evaluate Be a Mom for the promotion of mental health, in terms of its efficacy, acceptability and feasibility (user's adherence, dropout), user's satisfaction and cost-effectiveness.

The RCT will be a two-arm trial. Women with a child aged up to 3 months old will be enrolled in the study. A minimum number of 1000 women will be enrolled in the study. After agreeing to participate in the study, the women will be screened for the absence of risk factors for PPD (PDPI-R < 5.5). In case of a negative screen, women will be randomly assigned to one of two conditions: the intervention (Be a Mom program) or the control condition. The sample will be recruited online.

Participation in this study will last 15 months. The Be a Mom program will last 5 weeks. Participants in both conditions will be invited via email to complete baseline, post-intervention and follow-up assessments (4-months and 12-months after post-intervention). Assessments will include self-report questionnaires to assess several indicators (e.g., positive mental health, quality of life, marital satisfaction, depressive and anxiety symptoms, maternal self-efficacy), mechanisms that may be involved in the treatment response (e.g., self-compassion, emotional regulation), user's acceptability and satisfaction and cost-effectiveness.


Condition or disease Intervention/treatment Phase
Mental Health Wellness 1 Behavioral: Be a Mom Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Masking Description: Single-blind - the investigator is unaware of the intervention assignment
Primary Purpose: Other
Official Title: Promoting Maternal Mental Health: Applicability and Effectiveness of an eHealth Intervention for Portuguese Postpartum Women
Actual Study Start Date : January 15, 2019
Estimated Primary Completion Date : September 1, 2021
Estimated Study Completion Date : December 31, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: BeAMom
Low-risk (LR) women will receive a web-based intervention for the promotion of maternal mental health (the Be a Mom program). In addition, women will receive postpartum treatment as usually performed in primary care settings (TAU).
Behavioral: Be a Mom
The Be a Mom program is a web-based self-guided cognitive-behavioral intervention targeting postpartum women. It consists of 5 weekly modules, each targeting a specific thematic content, and providing women with both information and specific therapeutic strategies (with a strong focus on cognitive-behavioral techniques) to address each thematic content. Modules are sequential.

No Intervention: Control
Low-risk (LR) women will receive postpartum treatment as usually performed in primary care settings (TAU). During medical appointments, health professionals may ask women and provide information about psychological problems during the postpartum period.



Primary Outcome Measures :
  1. Changes from baseline in the presence of positive mental health [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with Mental Health Continuum-SF (MHC-SF; Keyes et al., 2008). The MHC-SF can be scored continuously (scores range from 0 to 70, and higher scores indicate better positive mental health) or categorically considering mental health status (flourishing, moderate mental health, languishing)


Secondary Outcome Measures :
  1. Changes from baseline in depressive symptoms [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1997). The total score ranges between 0 and 30, and higher scores are indicative of more severe depressive symptoms.

  2. Changes from baseline in anxiety symptoms [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Anxiety Subscale of the Hospital Anxiety and Depression Scale (HADS; Snaith & Zigmond, 1994). The total score ranges between 1 and 28, and higher scores are indicative of more severe anxiety symptoms.

  3. Changes from baseline in self-empowerment [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 months postintervention ]
    Measured with the Self-Empowerment Scale (SES; Rogers et al., 1997). The total score ranges between 0 and 100, and higher scores are indicative of higher self-empowerment.

  4. Changes from baseline in marital satisfaction: Marital Satisfaction Subscale of the Investment Model Scale [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Marital Satisfaction Subscale of the Investment Model Scale (IMS; Rusbult et al., 1998). The total score ranges between 0 and 60, and higher scores are indicative of higher relationship satisfaction.

  5. Changes from baseline in maternal self-efficacy [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Perceived Maternal Parenting Self-Efficacy Questionnaire (PMP S-E; Barnes & Macedo, 2007). The total score ranges between 1 and 80, and higher scores are indicative of a higher perceived maternal self-efficacy.

  6. Changes from baseline in psychological flexibility [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 2011). The total score ranges between 1 and 49, and higher scores are indicative of a higher psychological flexibility.

  7. Changes from baseline in self-compassion [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Self-Compassion Scale-SF (SCS-SF; Raes et al., 2011). The total score ranges between 1 and 48, and higher scores are indicative of higher self-compassion.

  8. Changes from baseline in emotional regulation [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Difficulties in Emotional Regulation Scale (DERS-SF; Kaufman et al., 2015). The total score ranges between 1 and 90, and higher scores are indicative of more difficulties in emotion regulation.

  9. Parental psychological flexibility [ Time Frame: Measured at follow-up (4 and 8 months postintervention) ]
    Measured with the Parental Acceptance Questionnaire (6PAQ; Greene et al., 2015). The total score ranges between 1 and 72, and lower scores are indicative of higher parental psychological flexibility.

  10. Acceptability of the program for postpartum women: Measured through specific questions [ Time Frame: Measured at post-intervention (8 weeks after randomization) ]
    Measured through specific questions (to be developed by the researchers) to assess acceptability.

  11. Feasibility of the program for postpartum women (Measured through the website utilization) [ Time Frame: Measured at post-intervention (8 weeks after randomization) ]
    Measured through the website utilization (e.g., number of logins, average visit length, total time spent on the website, number of exercises completed) and dropout rate.

  12. Medical Costs [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Treatment Inventory of Costs in Psychiatric Patients (TiC-P; Hakkaart-van, 2002)

  13. Health state and EQ-VAS [ Time Frame: From baseline to postintervention (8 weeks after randomization); 4 and 8 months postintervention ]
    Measured with the Euroqol Five Dimension Scale (EQ-5D; Euroqol Group, 1990). The EQ-5D consists of 2 pages: the EQ-5D descriptive system (used to generate a health state profile) and the EQ visual analogue scale (EQ VAS - used as a quantitative measure of health outcome that reflects the patient's own judgement). Each health state can be assigned a summary index score based on societal preference weights for the health state. These weights (or utilities) are used to compute QALYS. Health state index scores range from less than 0 (0 is a health state equivalent to death, negative values are valued as worse than death) to 1 (perfect health), with higher scores indicating higher health utility. Regarding the VAS, participant rates his/her perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Having 18 years or more;
  • Being female;
  • Having had a live healthy birth in the last 3 months, with both woman and the child discharged from hospital;
  • Internet access at home.
  • Absence of risk factors for Postpartum Depression (PDPI-R < 5.5).

Exclusion Criteria:

  • Current diagnosis of serious mental health condition (e.g., substance abuse, bipolar disorder);
  • Currently receiving treatment for depressive symptoms, including antidepressant medication or psychotherapy;
  • Language difficulties that impede comprehension/reading-writing;

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04055974


Contacts
Layout table for location contacts
Contact: Fabiana Monteiro, MsC +351915580072 fgmonteiro.91@gmail.com

Locations
Layout table for location information
Portugal
Faculty of Psychology and Education Sciences, University of Coimbra Recruiting
Coimbra, Portugal, 3000-115
Contact: Fabiana Monteiro, MsC    +351915580072    fgmonteiro.91@gmail.com   
Sponsors and Collaborators
University of Coimbra
Fundação para a Ciência e a Tecnologia
Investigators
Layout table for investigator information
Principal Investigator: Ana Fonseca, PhD University of Coimbra
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ana Fonseca, Principal Investigator, University of Coimbra
ClinicalTrials.gov Identifier: NCT04055974    
Other Study ID Numbers: SFRH/BD/115585/2016
First Posted: August 14, 2019    Key Record Dates
Last Update Posted: March 18, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ana Fonseca, University of Coimbra:
positive mental health
cognitive behavioral therapy
eHealth
postpartum period